Nutrivert Inc. — SEC Form D Filing
Nutrivert Inc. filed an SEC Form D on April 29, 2026, reporting $2.37M raised in Pharmaceuticals.
Form D filing details
- Filing
- SEC Form D
- Filing date
- April 29, 2026
- Amount reported
- $2.37M
- Round stage
- Seed
- Industry
- Pharmaceuticals
- Website
- https://www.nutrivertglobal.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
The high volume and cost of veterinary antibiotics in livestock production lead to a need for alternative solutions, especially since antibiotics are sometimes used at subtherapeutic levels that promote growth rather than address bacterial diseases.
Solution
Nutrivert Inc. is developing Nutrivert LDPP, a synthetic non-antibiotic compound that mimics bacterial cell components to promote growth and feed efficiency in livestock, while reducing inflammation.
Why now
With increasing awareness and regulations surrounding antibiotic use in livestock, there is a pressing need for effective alternatives that ensure animal health and food safety.
Verdict
Investors said yes at this moment because Nutrivert's narrative compellingly tied into rising regulatory pressures and consumer demand for antibiotic-free livestock solutions, not because the technology was clearly differentiated from existing alternatives. They were betting on growing momentum toward sustainable practices in agriculture, but the limited durability stems from competition with established players and potential for regulatory fatigue over time.
Source: SEC EDGAR Form D filing